Lucid Diagnostics Records More Than 1,800 EsoGuard Tests in October

Lucid Diagnostics outlined a faster commercial push for EsoGuard on Nov. 12, citing a record October volume of more than 1,800 tests and nationwide access through individual Medicare claim reviews.

Lucid has received Medicare payments on submitted EsoGuard claims at the established $1,938.01 Clinical Laboratory Fee Schedule rate. Claims are adjudicated individually, so the rate does not mean every test is automatically paid at that amount.

The payment process is independent of a pending MolDX coverage reconsideration. Lucid announced the reimbursement rate and the start of Medicare payments on Oct. 22; the newer update adds October testing volume and details on access through claim-by-claim adjudication.